These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37899385)

  • 1. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study.
    Chandra Shekhar H; Joshua L; Thomas JV
    Adv Ther; 2024 Jan; 41(1):246-261. PubMed ID: 37899385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
    Morin CM; Koetter U; Bastien C; Ware JC; Wooten V
    Sleep; 2005 Nov; 28(11):1465-71. PubMed ID: 16335333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).
    Barton DL; Atherton PJ; Bauer BA; Moore DF; Mattar BI; Lavasseur BI; Rowland KM; Zon RT; Lelindqwister NA; Nagargoje GG; Morgenthaler TI; Sloan JA; Loprinzi CL
    J Support Oncol; 2011; 9(1):24-31. PubMed ID: 21399726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia.
    Herrera-Arellano A; Luna-Villegas G; Cuevas-Uriostegui ML; Alvarez L; Vargas-Pineda G; Zamilpa-Alvarez A; Tortoriello J
    Planta Med; 2001 Nov; 67(8):695-9. PubMed ID: 11731907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
    Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
    Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
    Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
    Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.
    Taibi DM; Vitiello MV; Barsness S; Elmer GW; Anderson GD; Landis CA
    Sleep Med; 2009 Mar; 10(3):319-28. PubMed ID: 18482867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study.
    Langade D; Thakare V; Kanchi S; Kelgane S
    J Ethnopharmacol; 2021 Jan; 264():113276. PubMed ID: 32818573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia.
    Jacobs BP; Bent S; Tice JA; Blackwell T; Cummings SR
    Medicine (Baltimore); 2005 Jul; 84(4):197-207. PubMed ID: 16010204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
    Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
    Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
    Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
    Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
    Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
    J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.
    Walsh JH; Maddison KJ; Rankin T; Murray K; McArdle N; Ree MJ; Hillman DR; Eastwood PR
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34115851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of valerian root (Valeriana officinalis L.) vs. placebo in treatment of obsessive-compulsive disorder: a randomized double-blind study.
    Pakseresht S; Boostani H; Sayyah M
    J Complement Integr Med; 2011 Oct; 8():. PubMed ID: 22718671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
    Cuellar NG; Ratcliffe SJ
    Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.